201 related articles for article (PubMed ID: 15619510)
1. Are Ca2+ channels targets of praziquantel action?
Greenberg RM
Int J Parasitol; 2005 Jan; 35(1):1-9. PubMed ID: 15619510
[TBL] [Abstract][Full Text] [Related]
2. Ca2+ signalling, voltage-gated Ca2+ channels and praziquantel in flatworm neuromusculature.
Greenberg RM
Parasitology; 2005; 131 Suppl():S97-108. PubMed ID: 16569296
[TBL] [Abstract][Full Text] [Related]
3. [Study progress on the mode of action of praziquantel against schistosomes].
Xiao SH
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2007 Dec; 25(6):492-502. PubMed ID: 18441900
[TBL] [Abstract][Full Text] [Related]
4. [Research progress on the action of praziquantel on voltage-gated Ca2+ channel in schistosomes].
Zhang L; Zhou XN
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2008 Feb; 26(1):58-62. PubMed ID: 18637588
[TBL] [Abstract][Full Text] [Related]
5. New insight into praziquantel against various developmental stages of schistosomes.
Wu W; Wang W; Huang YX
Parasitol Res; 2011 Dec; 109(6):1501-7. PubMed ID: 21984370
[TBL] [Abstract][Full Text] [Related]
6. Voltage-gated calcium channel subunits from platyhelminths: potential role in praziquantel action.
Jeziorski MC; Greenberg RM
Int J Parasitol; 2006 May; 36(6):625-32. PubMed ID: 16545816
[TBL] [Abstract][Full Text] [Related]
7. Cytochalasin D abolishes the schistosomicidal activity of praziquantel.
Pica-Mattoccia L; Valle C; Basso A; Troiani AR; Vigorosi F; Liberti P; Festucci A; Cioli D
Exp Parasitol; 2007 Apr; 115(4):344-51. PubMed ID: 17083933
[TBL] [Abstract][Full Text] [Related]
8. Schistosomiasis control: praziquantel forever?
Cioli D; Pica-Mattoccia L; Basso A; Guidi A
Mol Biochem Parasitol; 2014 Jun; 195(1):23-9. PubMed ID: 24955523
[TBL] [Abstract][Full Text] [Related]
9. Schistosomiasis control: keep taking the tablets.
Hagan P; Appleton CC; Coles GC; Kusel JR; Tchuem-Tchuenté LA
Trends Parasitol; 2004 Feb; 20(2):92-7. PubMed ID: 14747023
[TBL] [Abstract][Full Text] [Related]
10. 'Death and axes': unexpected Ca²⁺ entry phenologs predict new anti-schistosomal agents.
Chan JD; Agbedanu PN; Zamanian M; Gruba SM; Haynes CL; Day TA; Marchant JS
PLoS Pathog; 2014 Feb; 10(2):e1003942. PubMed ID: 24586156
[TBL] [Abstract][Full Text] [Related]
11. [Studies on the mechanism of the antischistosomal action of praziquantel].
Xiao SH
Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1984; 2(3):196-8. PubMed ID: 6509755
[No Abstract] [Full Text] [Related]
12. Praziquantel.
Cioli D; Pica-Mattoccia L
Parasitol Res; 2003 Jun; 90 Supp 1():S3-9. PubMed ID: 12811543
[TBL] [Abstract][Full Text] [Related]
13. The anti-schistosomal drug praziquantel is an adenosine antagonist.
Angelucci F; Basso A; Bellelli A; Brunori M; Pica Mattoccia L; Valle C
Parasitology; 2007 Aug; 134(Pt 9):1215-21. PubMed ID: 17428352
[TBL] [Abstract][Full Text] [Related]
14. New approaches for understanding mechanisms of drug resistance in schistosomes.
Greenberg RM
Parasitology; 2013 Oct; 140(12):1534-46. PubMed ID: 23552512
[TBL] [Abstract][Full Text] [Related]
15. Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis.
Doenhoff MJ; Cioli D; Utzinger J
Curr Opin Infect Dis; 2008 Dec; 21(6):659-67. PubMed ID: 18978535
[TBL] [Abstract][Full Text] [Related]
16. Schistosome calcium channel beta subunits. Unusual modulatory effects and potential role in the action of the antischistosomal drug praziquantel.
Kohn AB; Anderson PA; Roberts-Misterly JM; Greenberg RM
J Biol Chem; 2001 Oct; 276(40):36873-6. PubMed ID: 11500482
[TBL] [Abstract][Full Text] [Related]
17. Specific sites in the Beta Interaction Domain of a schistosome Ca2+ channel beta subunit are key to its role in sensitivity to the anti-schistosomal drug praziquantel.
Kohn AB; Roberts-Misterly JM; Anderson PA; Khan N; Greenberg RM
Parasitology; 2003 Oct; 127(Pt 4):349-56. PubMed ID: 14636021
[TBL] [Abstract][Full Text] [Related]
18. Praziquantel derivatives exhibit activity against both juvenile and adult Schistosoma japonicum.
Duan WW; Qiu SJ; Zhao Y; Sun H; Qiao C; Xia CM
Bioorg Med Chem Lett; 2012 Feb; 22(4):1587-90. PubMed ID: 22264473
[TBL] [Abstract][Full Text] [Related]
19. Toward organometallic antischistosomal drug candidates.
Hess J; Keiser J; Gasser G
Future Med Chem; 2015; 7(6):821-30. PubMed ID: 25996072
[TBL] [Abstract][Full Text] [Related]
20. Praziquantel derivatives with antischistosomal activity: aromatic ring modification.
Wang ZX; Chen JL; Qiao C
Chem Biol Drug Des; 2013 Aug; 82(2):216-25. PubMed ID: 23617439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
